Dubai, United Arab Emirates - Friday, 21. March 2025
Dubai Electricity and Water Authority PJSC (ISIN: AED001801011) (Symbol: DEWA), the Emirate of Dubai’s exclusive electricity and water services provider, which is listed on the Dubai Financial Market (DFM), reported that its shareholders have, in the general assembly held on 21 March 2025, approved the payment of total dividend of AED 3.1 billion for H2 of 2024, with a record date of 31 March 2025.
The meeting, chaired by HE Matar Humaid Al Tayer, Chairman of the Board of Directors of DEWA, was attended by HE Saeed Mohammed Al Tayer, MD&CEO of DEWA and Members of the Board of Directors of DEWA as well as 92.2% of the shareholders. During the meeting, a Board of Directors was elected for the next three years. For shareholders who are invested in DEWA’s shares prior to the dividend record date of 31 March 2025 (with a Last Entitlement Date of 27 March 2025), the next twelve-month dividend yield is 5.0% with reference to IPO share price of AED 2.48 per share.
"Our commitment to sustainable growth, innovation and value creation remains stronger than ever. We continue to drive efficiency, invest in future-ready solutions and strengthen our role as a global leader in clean energy and digital transformation. We are not only meeting the increasing demand for electricity and water but also pioneering the transition towards a cleaner and more sustainable energy future. The past year is a testament to DEWA’s resilience, adaptability and forward-thinking approach. Through cutting-edge technologies, smart solutions, and world-class governance, DEWA continues to set new benchmarks in operational and financial excellence,” said HE Matar Humaid Al Tayer, Chairman of DEWA.
HE Saeed Mohammed Al Tayer, MD & CEO of DEWA, said: “DEWA remains steadfast in its commitment to excellence, sustainability and long-term growth. In 2024, DEWA Group delivered another year of strong performance, reporting consolidated full-year revenue of AED 30.98 billion, EBITDA of AED 15.73 billion and net profit after tax of AED 7.23 billion Our consolidated annual revenue grew by 6.17%, primarily driven by rising demand for electricity, water, and cooling services.”
Audited Financials
DEWA’s audited financials can be found at DEWA’s website: https://www.dewa.gov.ae/en/investor-relations or DFM’s website https://www.dfm.ae/en/issuers/listed-securities/securities/company-profile-page?id=DEWA
Permalink
https://www.aetoswire.com/en/news/dewa21032025en
Contacts
Dubai Electricity and Water Authority
Shaikha Almheiri, +971552288228
shaikha.almheiri@dewa.gov.ae
Friday, March 21, 2025
The smarter E AWARD 2025: Energy Transition Pioneers Shortlisted
MUNICH & PFORZHEIM, Germany -
(BUSINESS WIRE) -- The winners of The smarter E AWARD 2025 will be honored on 6 May at the International Congress Center Messe München. The finalists are the following.
Finalists in the Photovoltaics category
7Secondsolar (South Africa) with its AUTOPV planning software solution
Aevy (Norway) with its Aevy asset management platform
Aiko Energy (China) with its ABC INFINITE PV module
Anhui Huasun Energy (China) with its Kunlun Series Ultra-high Bifaciality HJT solar module
LONGi Solar Technology (China) with its Hi-MO X10 module
MBJ Solutions (Germany) with its MBJ Sunlike Lab solar simulator
Seaward Electronic (UK) with its PV:1525-IV testing device
Sungrow Power Supply (China) with its SG350HX-20 string inverter
Sunmaxx PVT (Germany) with its Sunmaxx PX-1 combination module
Weidmüller Interface (Germany) with its PV Inline lightning and overvoltage protection
Finalists in the Energy Storage category
CMBlu Energy (Germany) with its Organic SolidFlow Battery storage system
EcoFlow (China) with its PowerOcean DC Fit residential storage system
EVE Energy (China) with its Mr. Big battery cell
Huawei Technologies (China) with its ESS LUNA2000-215-2S10 storage system
Hydrostor (Canada) with its A-Compressed Air Energy Storage (A-CAES) system
p&e power&energy (Germany) with its Scalable Cell Level Power Electronics Platform inverter system
SAMSUNG SDI (South Korea) with its U8A1 UPS solution
SOL Research (Germany) with its Powerstation 2.500
Sungrow Power Supply (China) with its PowerTitan 2.0 large-scale storage system
Xiamen Hithium Energy Storage Technology (China) with its Power 6.25 MWh 4h BESS battery container
Finalists in the E-Mobility category
Cable-Sherpa (Austria) with its Cable-Sherpa cable management
DEHN (Germany) with its DEHNguard M DC ACI 1250 FM power protection switch
Etecnic (Spain) with its EVcharge Software-as-a-Service (SaaS) platform
Friedrich (Germany) with its URBANROOF parking lot canopy
GoodWe (China) with its Vela Series Residential Solar Carport
Hive Power (Switzerland) with its Hive Power FLEXO Smart Charge SaaS solution
SAMSUNG SDI (South Korea) with its No Thermal Propagation Technology battery concept
Schaltbau (Germany) with its C330 high-power DC contactor
Shenzhen Kehua Hengsheng Technology (China) with its EV3102-040K-HR-UC SiC charging module
OPES Solar Mobility (Germany) with its O.Motion matrix solar module series
Schaltbau (Deutschland) mit dem Hochleistungs-DC-Schütz C330
Shenzhen Kehua Hengsheng Technology (China) mit dem SiC-Lademodul EV3102-040K-HR-UC
OPES Solar Mobility mit der Matrix-Solarmodul-Serie O.Motion
Finalists in the Smart Integrated Energy category
FENECON (Germany) with its FEMS FENECON energy management system
meteocontrol (Germany) with its mc Assetpilot
fleXality (Germany) with its AI-based fEnOMS software solution
Sungrow Power Supply (China) with its Stem Cell Grid Technology grid-forming inverter technology
Toscano (Spain) with its COMBI-PRO-MAX switching solution
Utiligize (Denmark) with its integrated Forecast & Investment platform
Zählerfreunde (Germany) with its white label energy management SaaS solution for utilities
Finalists in the Outstanding Projects category
Beijing HyperStrong Technology (China) with its Beijing Siyuanqiao Integrated Charging Plus Storage Station Project
Beijing HyperStrongTechnology (China) with its 250 MW/1,000 MWh energy storage project in Santanghu
CyberGrid (Austria) with its Theiß Hybrid Storage System
Electricity Authority of Cyprus (Cyprus) with its installation of PV systems in 405 public schools
GIZ Indonesia (Indonesia) with its off-grid Solar Ice Maker project for fishing communities
Karlsruhe Institute of Technology – KIT (Germany) with its BiFlow hybrid storage system project
LONGi Solar Technology (China) with its 3000 Nm³/h Electrolyzer in Hydrogen-Rich Blast Furnace Smelting project
Phaesun (Germany) with its BeCool: Clean Cooling for Markets in Kenya project
Sungrow Hydrogen (China) with its Low Carbon Institute Green Hydrogen Demonstration Project
Xiamen Ampace Technology (China) with its energy storage project integrated into a high-voltage transformer station in Chile
View source version on businesswire.com: https://www.businesswire.com/news/home/20250320037540/en/
Permalink
https://www.aetoswire.com/en/news/2003202545519
Contacts
Solar Promotion GmbH | Peggy Härter-Zilay | Tel.: +49 7231 58598-240
haerter-zilay@solarpromotion.com
PUMA Redefines the Game: Unveiling a Bold Strategy and Brand Positioning With ‘Go Wild’ Campaign
HERZOGENAURACH, Germany - Thursday, 20. March 2025 AETOSWire
(BUSINESS WIRE)--Global sports company PUMA announces the launch of its biggest global brand campaign to date – ‘Go Wild’ – marking an evolution in its brand identity and showing runners re-arranging their lives to chase the highs of running. The campaign celebrates the individual and inspires everyone – amateurs and professional athletes alike – to unleash their true selves and discover greatness in their nature.
For 75 years, PUMA has relentlessly pushed sport and culture forward and, as a leading sport brand, has always promoted sport as a way to embrace self-expression and joy. Through the launch of 'Go Wild', PUMA is championing the power of unveiling your true self through sport, showing it’s about the courage to be yourself, unlocking your authentic self and in turn, unleashing your greatness.
“PUMA has always been home to athletes who achieved greatness in sports by being their true selves and following their own path to success,” says Arne Freundt, CEO at PUMA. “Iconic personalities from the past and the present like Tommie Smith, Usain Bolt, Breanna Stewart or Neymar are great ambassadors of the unique PUMA DNA: our athletes with a great personality embracing self-expression and joy. With our second brand campaign, we are taking another important step in strengthening our distinctive and emotional connection with our consumers in our brand elevation journey.”
Beyond just idolising performance, PUMA aims to inspire individuals to unleash their wild energy through sport. By capturing the human instinct, we all feel when playing sport, PUMA aims to expand its global presence and make more meaningful connections with its audience.
“This new brand campaign represents a new vision for sport and a new chapter for PUMA, aligned with the expectations of a younger generation and rooted in PUMA’s history. In times of social media followership and ‘meme’ culture, we want to inspire the professional and everyday athletes to look inside themselves to find their own greatness and have the courage to unleash their true self,” says Richard Teyssier, Global VP Brand and Marketing at PUMA.
The 2025 campaign kicks off with the release of the ‘Go Wild’ hero film, a tribute to runners unlocking the runner’s high – a rush of happy chemicals released during physical activity – aligning with a positive audience response in this space and rooted in the belief that running is at its best when you chase the runner’s high. The ‘Go Wild’ film moves away from featuring athletes and celebrities – and instead celebrates the everyday runner, including the early-rising runners, a runner with their dog, a new mum, or running as a community – all of them making choices staying true to themselves chasing the high of a run.
To further sustain the ‘Go Wild’ message, PUMA will be launching a series of content which aims to explain ‘Go Wild’ to its audience through PUMA’s ambassadors’ stories. From Tommie Smith in 1968 and Usain Bolt in 2008 to Mondo Duplantis in 2024, self-expression through sport has always been at the heart of PUMA’s ambassadors. Like no other, they know what it means to go wild, and they are our Wild Ones.
The ‘Go Wild’ global campaign goes live on 20th March and will continue through 2025/26 by strategically spotlighting different categories within sport, including basketball and football, and leveraging key global sporting events.
For more information about PUMA Go Wild, visit www.puma.com or follow our journey on social media @PUMA.
Notes to editors:
Brand film, long version: LINK
Brand film, short versions: LINK
Brand film on YouTube: LINK
Images: LINK
PUMA
PUMA is one of the world’s leading sports brands, designing, developing, selling and marketing footwear, apparel and accessories. For 75 years, PUMA has relentlessly pushed sport and culture forward by creating fast products for the world’s fastest athletes. PUMA is committed to redefining sport and self-expression, empowering athletes and consumers to perform at their best while staying true to who they are. With a focus on innovation, authenticity, and joy, PUMA continues to push the boundaries of performance and sports-style. PUMA offers performance and sport-inspired lifestyle products in categories such as Football, Running and Training, Basketball, Golf, and Motorsports. It collaborates with renowned designers and brands to bring sport influences into street culture and fashion. The PUMA Group owns the brands PUMA, Cobra Golf and stichd. The company distributes its products in more than 120 countries, employs about 20,000 people worldwide, and is headquartered in Herzogenaurach/Germany.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250320977547/en/
Permalink
https://www.aetoswire.com/en/news/2003202545504
Contacts
Media contacts:
PUMA
Kseniia Iliushina
Global Brand PR Manager
Kseniia.iliushina@puma.com
Mario Almeida
Director of Global PR & Brand Activations
mario.almeida@puma.com
NTT DATA Launches Agentic AI Services for Hyperscaler AI Technologies
LONDON - Friday, 21. March 2025 AETOSWire
NTT DATA delivers end-to-end Agentic AI services to drive unprecedented efficiencies, accelerate innovation and deliver measurable business outcomes
Comprehensive suite of cloud-managed services helps organizations harness the full potential of agentic AI, leveraging hyperscaler AI technologies
Builds on NTT DATA Smart AI Agent delivering scalable, AI-powered automation for clients
(BUSINESS WIRE)--NTT DATA, a global leader in digital business and technology services, today announced the launch of its Agentic AI Services for Hyperscaler AI Technologies. This transformative suite of services helps organizations easily adopt, build, manage and scale AI-powered agents to improve efficiencies, unlock innovation and enhance employee and customer experiences, maximizing returns on AI investments.
This unique suite of services addresses the growing demand for agentic AI solutions that offer personalized experiences. This news builds on NTT DATA’s recently announced Smart AI Agent™, enabling enterprises to integrate AI-driven automation across business functions. Unlike traditional automation, Agentic AI understands user needs, engages naturally and handles complex interactions, empowering organizations to confidently scale their AI capabilities while ensuring optimization and success.
NTT DATA’s Agentic AI Services for Hyperscaler AI Technologies offers the industry’s most comprehensive suite of services for AI. These services support every stage of an organization’s agentic AI journey with cloud providers – from advisory and building AI agents to implementation, connectivity and ongoing managed services.
Applicable across all industries including manufacturing, banking and healthcare, these services help organizations maximize AI investments and responsibly innovate while ensuring ongoing optimization and success. Available in over 20 languages across every major market, NTT DATA ensures seamless global adoption.
By integrating its agentic AI with generative AI, including large and small language models, these AI agents can perform tasks more rapidly, accurately and efficiently with fewer errors. NTT DATA also helps to ensure clients that once AI agents are deployed, they remain secure, up-to-date and continuously improved. By connecting AI agents to hyperscaler data centers, NTT DATA helps to enable more personalized, natural interactions, making AI-driven services more intuitive and effective.
Meeting the demand for scalable AI solutions
Enterprise AI investments are accelerating. According to Gartner®, “by 2028, the market for artificial intelligence services will reach $609 billion with a five-year annual growth rate of 21.4% in constant U.S. dollars.” Additionally Gartner also states that “By 2028, “33% of enterprise software applications will include agentic AI, up from less than 1% in 2024, enabling 15% of day-to-day work decisions to be made autonomously.”
NTT DATA’s own Global GenAI Report reflects this trend, showing organizations are increasingly prioritizing agentic AI for back-office and workflow optimization in 2025. The report also found that 96% of CIOs and CTOs prefer cloud-based solution methods.
“Agentic AI will revolutionize business operations and NTT DATA is at the forefront of this transformation,” said Charlie Li, Global Head of Cloud & Security, NTT DATA, Inc. “As the first global provider to offer comprehensive agentic AI services with a focus on AI agent management, we are empowering organizations to invest in AI agents with confidence– unlocking unprecedented efficiency and innovation while enhancing the experiences they provide to their employees and customers.”
Flexible agentic AI services
NTT DATA’s Agentic AI Services for Hyperscaler AI Technologies are available in flexible packages, allowing organizations to scale AI adoption with industry leading support that can easily align to clients’ budgets, resources and timeframes.
Advisory services: Guidance on adopting and optimizing agentic AI solutions, including planning, design, GenAI, business process optimization and automation tailored to specific business needs.
Implementation services: AI agent configuration, integration and deployment focused on security, compliance and performance optimization with complementary change management options.
Ongoing AI management services: Continuous monitoring, troubleshooting, data governance and detailed reporting and analytics.
Connectivity: Seamless connectivity across all channels using NTT DATA’s cloud-native global connectivity services for voice, chat and mobile integration, ensuring consistent monitoring and compliance with local regulations.
Advanced expertise to accelerate innovation with hyperscalers
NTT DATA is uniquely positioned to deliver innovative and comprehensive capabilities and services as a systems integrator, managed services provider and carrier. This allows for faster and more efficient deployment of AI agents anchored in our commitment to responsible AI.
NTT DATA is launching its Agentic AI Services for Hyperscaler AI Technologies with an initial focus on Microsoft platforms. As the leading Microsoft Cloud Voice partner and a top provider of Copilot for Microsoft 365, NTT DATA is well-positioned to help enterprises integrate AI agents into their daily operations.
By leveraging cutting-edge tools such as Azure AI Foundry and Copilot Studio, NTT DATA agents are equipped to deliver even more innovative and effective solutions to clients.
“AI-powered agents are transforming how businesses operate, and we are excited to collaborate with NTT DATA to help organizations embrace this new era of AI-powered innovation,” said Maziar Zolghadr, General Manager Global Communications Partners, Microsoft. “Combining Microsoft’s AI technologies with NTT DATA’s expertise in AI agent building, deployment and management we are empowering enterprises to create more intelligent experiences for their employees and clients.”
Real-world applications across industries
NTT DATA’s Agentic AI Services for Hyperscaler AI Technologies offer solutions across functions and use cases, providing easy-to-implement solutions such as:
Customer service: Automating query resolution and enabling self-service to reduce wait times.
Billing and scheduling: Streamlining repetitive tasks to save time and improve operational efficiency.
Training and onboarding: Accelerating employee onboarding and skills development.
Logistics and risk management: Enhancing processes like fraud protection and data analysis for insight-driven decisions.
HR and sales assistants: Offering voice, chat and messaging options for improved communication and task management.
Workflow automation: Smart assistants optimize task routing process management.
Future growth and expansion
With today’s launch, NTT DATA builds on its established GenAI capabilities, further strengthening its position as a leader in AI-driven enterprise solutions.
NTT DATA’s Agentic AI Services for Hyperscaler AI Technologies are designed to work with a wide range of AI platforms and will continue to expand to support new technologies. These services are integral to NTT DATA’s broader managed services portfolio across cloud, networking and cybersecurity.
NTT DATA Smart AI Agent offers a comprehensive end-to-end and full-stack solution that includes AI agents consulting, platforms, third-party integrations and managed services to transform business processes across industries. By streamlining operations and enhancing efficiency, Smart AI AgentTM empower businesses to rapidly evaluate and deploy generative AI applications, optimize workflows and drive greater productivity.
About NTT DATA
NTT DATA is a $30+ billion trusted global innovator of business and technology services. We serve 75% of the Fortune Global 100 and are committed to helping clients innovate, optimize and transform for long-term success. As a Global Top Employer, we have diverse experts in more than 50 countries and a robust partner ecosystem of established and start-up companies. Our services include business and technology consulting, data and artificial intelligence, industry solutions, as well as the development, implementation and management of applications, infrastructure and connectivity. We are also one of the leading providers of digital and AI infrastructure in the world. NTT DATA is part of NTT Group, which invests over $3.6 billion each year in R&D to help organizations and society move confidently and sustainably into the digital future.
Visit us at nttdata.com.
*Gartner, Forecast Analysis: Artificial Intelligence Services, Worldwide, Colleen Graham, Christopher Marshall, et al., 27 August 2024 (For Gartner Subscribers only)
*Gartner Article, Intelligent Agents in AI Really Can Work Alone. Here’s How. By Tom Coshow | October 1, 2024
*GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
* Smart AI Agent is a trademark of NTT DATA Group Corporation.
* Other product, company and organization names are trademarks or registered trademarks of the respective companies.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250320628624/en/
Permalink
https://www.aetoswire.com/en/news/2103202545526
Contacts
Lori Bosio
External Communications, NTT DATA, Inc.
lori.bosio@global.ntt
Caldera Medical Acquires Ethicon’s GYNECARE TVT™ Family of Products in Transformational Expansion Globally for Women’s Health Company
LOS ANGELES - Thursday, 20. March 2025 AETOSWire Print
(BUSINESS WIRE) -- Caldera Medical, a leader in women's health medical devices, has acquired Ethicon’s Gynecare TVT™ family of products and will transition the products in the coming months. This strategic milestone builds on Caldera Medical’s 23-year commitment to delivering best-in-class therapies that improve the quality of life for women worldwide.
The TVT product line - consisting of TVT, TVT Exact, TVT-O and TVT Abbrevo, provides minimally invasive treatment options for women with stress urinary incontinence (SUI). As part of the acquisition, Caldera Medical will maintain the same manufacturing facility, materials, and dedicated manufacturing team behind the TVT products, ensuring a seamless transition for surgeons, patients, and partners. With more than two decades of clinical data, including 20-year patient follow-up, the trusted performance and efficacy of TVT remain unchanged.
“This acquisition marks a significant advancement in our mission to transform women’s health,” said Bryon Merade, CEO of Caldera Medical. “By bringing the TVT product line into our portfolio, we reinforce our unwavering commitment to providing safe, effective solutions for surgeons and their patients. We are honored to build on the legacy and expand the reach of this esteemed product family, delivering proven treatments to more women around the world.”
Caldera Medical will expand global customer support for TVT over the next several months and invest in advancing care for a greater number of women. Combining Caldera Medical’s established expertise in pelvic health with TVT’s demonstrated success, the company further solidifies its position as a premier provider of advanced solutions for women. This acquisition follows the September 2023 acquisition of Atlantic Therapeutics with the Innovo non-invasive solution for bladder leaks and the October 2024 acquisition of UVision360 with the Luminelle product line for hysteroscopy and cystoscopy. These acquisitions not only accelerate Caldera Medical’s growth but underscore its dedication to broadening access to life-changing treatments, backed by a legacy of clinical success and a focus on improving patient outcomes.
About Caldera Medical
Caldera Medical is a leading innovator in the field of women’s health, specializing in the development, manufacturing, and marketing of advanced medical devices for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse, and gynecologic conditions such as polyps and fibroids. With a focus on minimally invasive surgical solutions, Caldera Medical is committed to its mission of improving the quality of life for women globally. In collaboration with its surgeon partners, Caldera Medical operates the largest humanitarian program in women’s health, with the goal of providing care to one million underserved women worldwide by 2027. Learn more at www.calderamedical.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250320644274/en/
Permalink
https://www.aetoswire.com/en/news/2003202545518
Contacts
Caldera Medical Media Relations
pr@calderamedical.com
World Crisis and Emergency Management Summit Set to Launch on 8 April in Abu Dhabi
Abu Dhabi, United Arab Emirates
The National Emergency Crisis and Disaster Management Authority (NCEMA) has announced the launch of the ‘World Crisis and Emergency Management Summit’ 2025 under the theme "Together Towards Building Global Resilience". The event will take place at the Abu Dhabi National Exhibition Centre (ADNEC) on April 8-9, featuring the largest international participation in the summit’s history.
The summit aims to enhance international cooperation in crisis management, provide innovative solutions to address growing global challenges, and foster discussions and workshops that bring together thought leaders and decision-makers from around the world.
The press conference also announced two key co-located exhibitions namely: the ‘Crisis Management Technologies Exhibition’, which will showcase the latest technological innovations in emergency management, and the ‘Generation Readiness Exhibition’ dedicated to raising community awareness about disaster preparedness as part of national efforts to enhance readiness and effective response to any future challenges.
Mariam Yaed Al Qubaisi, Official Spokesperson and Chairperson of the Organizing Committee of the Summit, emphasized the UAE’s pioneering role in building a comprehensive global response system based on innovation, future foresight, and international partnerships.
Al Qubaisi said: “This edition of the summit will focus on global resilience-building, leveraging modern technology, enhancing strategic planning, and developing proactive strategies to tackle crises. We will also discuss global best practices in risk prediction, rapid response, and effective recovery to ensure community protection and strengthen resilience against future challenges”.
The summit’s main sessions will cover critical topics, including strategic emergency planning, the role of advanced technology in risk prediction, and the importance of international collaboration to ensure a coordinated and rapid response. The event will also feature workshops, panel discussions, and the signing of cooperation agreements between government and private sector entities to facilitate knowledge exchange and develop integrated global crisis management policies.
Salman Ali Al Salman, Official Spokesperson for the co-located exhibitions said: “The Exhibitions aim to highlight the role of modern technology in improving crisis response and promote a culture of emergency preparedness among the community.”
The summit is set to attract a diverse range of participants, including ministers, government officials, crisis and emergency management experts, representatives from international organizations, academia, and the private sector.
Registration: (www.wcems.ae).
Permalink
https://www.aetoswire.com/en/news/wcems20032025en
Contacts
Farah Abo Salah
+971507483040
farah.abosalah@gmail.com
AMWC 2025: Galderma Pushes the Innovation Frontier With Updates From Its Unparalleled Portfolio Designed to Meet the Needs of the Aesthetic Community
ZUG, Switzerland
Galderma will present new data from across its portfolio, including findings from the RELAX and EXPRESSION studies on Relfydess® (RelabotulinumtoxinA) highlighting its rapid onset of action as early as day one and sustained high patient satisfaction beyond six months1,2
New in vivo data on Sculptra® (PLLA-SCA), the first proven regenerative biostimulator, will be presented, showing its lower inflammatory response compared to PLLA-GA, which can significantly impact local tissue response and product degradation and therefore may impact the duration of clinical effect3-12
Additionally, results from the first-of-its-kind and largest survey on facial changes associated with medication-driven weight loss will be presented showing many patients would consider aesthetic treatments to address these changes, with biostimulators and dermal fillers the most frequently considered13
Galderma will host a symposium exploring how aesthetic treatments can address facial changes associated with medication-driven weight loss in addition to a second symposium dedicated to achieving the ideal lips with Restylane® Kysse™
In total, Galderma will present 11 e-posters, including additional updates on Restylane, and host two symposia, four Masterclass sessions, five Meet-the-Expert sessions, an experiential lounge and an interactive booth, reinforcing its strong leadership position in Injectable Aesthetics
(BUSINESS WIRE)--Galderma (SWX:GALD) will showcase a strong presence at the 23rd Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monaco from March 27-29, 2025, with two symposia, four Masterclass sessions, 11 research e-posters, and an experiential Galderma lounge alongside its interactive booth (O2, Hall Ravel) featuring five Meet-the-Expert sessions. This extensive program highlights the breadth of Galderma’s leading Injectable Aesthetics portfolio, designed to address the present and future needs of patients and healthcare professionals alike.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250319676050/en/
“With our extensive presence at AMWC 2025, we have a valuable platform to engage with the aesthetics community while showcasing the broadest portfolio in the industry. Through our data presentations and expert-led sessions, we reaffirm our commitment to being a leading force in advancing the field of Injectable Aesthetics and equipping healthcare professionals with the innovative solutions they need to fulfill the needs of patients, today and tomorrow.”
BALDO SCASSELLATI SFORZOLINI, M.D., Ph.D.
GLOBAL HEAD OF R&D
GALDERMA
Expert perspectives on the hottest topics in injectable aesthetics today
Rates of medication-driven weight loss have increased rapidly in recent years and can be associated with alterations in facial aesthetic appearance of variable magnitude.14 In the largest study investigating facial changes in medication-driven weight loss to date, Galderma surveyed more than 1,300 people across five countries.13 Findings from this first-of-its kind study will be presented, showing 93% of those undergoing weight loss treatment noticed some degree of facial changes during their treatment and many patients are considering aesthetic treatments to address these, with biostimulators and dermal fillers being the most frequently considered treatments.13 The Galderma-sponsored “Medication-Driven Weight Loss: The Algorithms" symposium taking place on Thursday, March 27, as well as a dedicated Masterclass session on Friday, March 28, will explore the effects medication-driven weight loss can have on the face and dive into the ways aesthetic procedures can help restore facial volume and structure. The symposium will feature live demonstrations and expert insights from Dr. Luiz Avelar, Dr. Priyanka Chadha, Prof. Sebastian Cotofana, Dr. Sabrina Fabi, Dr. Marcus Morais, and Dr. Andreas Nikolis.
Galderma will also host the "GAIN Experts Dialogue: Defining the Ideal Lips" symposium on Thursday, March 27, featuring expert speakers Prof. Sebastian Cotofana, Dr. Simone Doreian, Dr. Stephanie Lam, Dr. Christoph Martschin, and Dr. Andrei Metelitsa. This session, through insightful debates, cultural and anatomical discussions, and live injection demonstrations, will explore the evolving techniques in aesthetic lip treatments as well as patient standards and preferences for natural looking and feeling results. A Masterclass session will also be held to dive deeper into these techniques on Saturday, March 29.
New data cements the unique ability of Galderma’s products to meet patient needs
Galderma will present new data from the phase IIIb EXPRESSION and RELAX studies, showing Relfydess achieved rapid onset of action and significant aesthetic improvement in frown lines and crow’s feet.1,2 In the EXPRESSION study more than 50% of patients reported visible effects as early as day one and, in the RELAX study, effects were sustained through six months, confirming results seen in the READY trial program and more than a third saw improvement beyond six months in frown lines.1,2 Both studies re-confirmed high patient satisfaction with Relfydess, with 70% of patients in the RELAX study reporting that they preferred treatment with Relfydess versus prior treatments received.1,2 Encore data from a post-hoc analysis of the phase III READY program will show that, regardless of baseline wrinkle severity (moderate/severe), subjects treated with Relfydess achieved high rates of improvement in frown lines and crow’s feet, along with improved well-being, and a sustained effect through six months.15
Galderma will also present new data on Sculptra (PLLA-SCA), the first proven regenerative biostimulator, reinforcing its unique formulation, efficacy, and safety.3-12 New in vivo comparative data will demonstrate its favorable tissue response and slower, controlled product degradation profile at 52 weeks, as well as lower inflammation, compared to PLLA-GA.11 The lower inflammation is consistent with Sculptra's well-established safety profile.3 Differences in formulation can significantly impact local tissue response and product degradation, affecting potential clinical outcomes such as efficacy and duration.11 An expert consensus also confirms Sculptra’s key role in the regenerative aesthetic field and additional data will show its synergistic effect when paired with Alastin®, underscoring its effect across all three skin layers.12,16
Encore data to be presented on Restylane Shaype™, powered by Galderma’s proprietary NASHA HD™ Technology and approved in Canada and most recently in Brazil, will show that it constitutes a breakthrough innovation in hyaluronic acid fillers as the firmest hyaluronic acid injectable available and displaying the highest G-prime (indicating superior gel strength and firmness) on the market providing a unique bone mimicking effect.17,18 Additional pooled and pivotal phase IV data to be presented will show that Restylane fillers preserve or enhance the natural expressions of 98% of patients while achieving desired aesthetic improvements in attractiveness and youthfulness.19 This naturalness, combined with high patient satisfaction, represents long-lasting aesthetic improvement.19 To date, Restylane is the first and only hyaluronic acid filler to have in vivo data demonstrating its efficacy in restoring and maintaining the naturalness of expression.19-22
These e-posters, along with others presented on Dysport® and Alastin, will reinforce Galderma’s strong dedication to equipping practitioners with the products they need to achieve natural, long-lasting results for their patients.
More details on Galderma’s scientific presentations at AMWC can be found here. Media can watch this video to find out more about facial changes associated with medication-driven weight loss and this video to learn more about the natural looking results of Restylane products.
About Relfydess (RelabotulinumtoxinA)
Pioneered by Galderma, Relfydess is the first and only ready-to-use liquid neuromodulator created with PEARL™ Technology that is designed to preserve molecule integrity.23 PEARL Technology is designed to deliver a highly active, innovative, complex-free molecule, with up to 39% of patients seeing effects from day one and up to 75% of patients maintaining improvements for six months.24-27 Relfydess is optimized for simple volumetric dosing, without reconstitution, to increase ease-of-use and help ensure consistent dose/volume every time.23,28 It was entirely created and manufactured by Galderma to expand its neuromodulator portfolio as part of the broadest Injectable Aesthetics portfolio on the market. Relfydess received a marketing authorization in several markets. RelabotulinumtoxinA is an investigational drug product in the U.S. Authorization conditions may vary internationally.
About the Restylane Portfolio
Restylane hyaluronic acid (HA) injectables are Designed Differently to go beyond volumizing for natural-looking results.29-32 Our HA is exceptionally pure, making it the closest to the skin’s own.33 Our innovative manufacturing process preserves its biocompatibility while creating individual products designed for a specific purpose. Restylane unique technologies, NASHA HD™, NASHA® and OBT™ are meaningfully designed to mimic the diverse range of facial structures and skin layers.29-31 With the Highest G’ and Highest flexibility, Restylane can provide from structural support to natural expression to a healthy glow.17,30,33-36 Trusted for almost three decades, our HA gels work in sync with your skin for 100% natural looking results.22,29,37
About Sculptra
Sculptra is the first proven regenerative biostimulator, with a unique PLLA-SCA™ formulation that helps restore the deep, underlying structure of the skin by inducing a foreign body reaction.3,48-10,38-47 Sculptra works to address the underlying causes of facial aging, including degradation of the extracellular matrix, which results in volume loss, laxity, and the appearance of wrinkles.3,41,45-47 Sculptra encourages the remodeling of components of the extracellular matrix, such as elastin and collagen, helping to gradually restore facial volume and the look of fullness to wrinkles and folds over time.48-51 The results from Sculptra are long-lasting, with optimal correction seen in approximately three months and results lasting up to two years.4,46,7,52
About Galderma
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.
References
Shridharani S, Coquis-knezek S and Prygova I. Aesthetic improvement and rapid results in glabellar and lateral canthal lines after treatment with the innovative liquid relabotulinumtoxinA formulation. Presented at AMWC 2025; Mar 27-29, 2025; Monaco
Ablon G, et al. Subject preference and satisfaction with liquid relabotulinumtoxinA treatment of glabellar lines over 12 months, in a randomized controlled trial. Presented at AMWC 2025; Mar 27-29, 2025; Monaco
Galderma. Sculptra EU Instructions For Use 2023
Widgegrowl J, et al. A randomized, comparative study describing the gene signatures of poly-l-lactic acid (PLLA-SCA) and calcium hydroxylapaptite (CaHA) in the treatment of nasolabial folds). IMCAS Poster 2024. Paris, France
Galderma. Data on file. MA-50526. 43USSA1812 clinical study report. Fort Worth, TX: Galderma Laboratories, L.P. 2022
Bohnert K, et al. Randomized, Controlled, Multicentered, Double-Blind Investigation of Injectable Poly-L-Lactic Acid for Improving Skin Quality. Dermatol Surg 2019;45:718–724
Hexsel D, et al. Introducing the L-Lift—A Novel Approach to Treat Age-Related Facial Skin Ptosis Using A Collagen Stimulator. Dermatol Surg: Letters & Communications. 2019
Galderma. Data on File (MA-60875)
Zhang Y, et al. In vivo inducing collagen regeneration of biodegradable polymer microspheres. Regen Biomater. 2021;8(5):rbab042. doi: 10.1093/rb/rbab042
Huth S, et al. Molecular Insights into the effects of PLLA_SCA on Gene Expression. J Drugs Dermatol. 2024;23(4):285-288. doi: 10.36849/JDD.7791
Avelar L, et al. Comparing two biostimulators on the local tissue response and degradation up to 52 weeks in vivo with an indirect comparison to clinical outcomes. Presented at AMWC 2025; Mar 27-29, 2025; Monaco
Fabi S, et al. Regenerative aesthetic effects of poly L-lactic acid (PLLA-SCA) treatment. Presented at AMWC 2025; Mar 27-29, 2025; Monaco
Nikolis A, Prygova I and Brasatar D. The potential role of biostimulators/dermal fillers to address the impact of medication driven weight loss management treatments on facial appearance. Presented at AMWC 2025; Mar 27-29, 2025; Monaco
Humphrey CD & Lawrence AC. Implications of Ozempic and other GLP-1 receptor agonists for facial plastic surgeons. Facial Plast Surg. 2023;39:719-721
Ablon G, et al. RelaBoNT-A treatment of glabellar lines and lateral canthal lines of different baseline severity: subgroup analyses of pooled Phase III study data. Presented at AMWC 2025; Mar 27-29, 2025; Monaco
Markowitz O, et al. Evaluation of synergistic effects for midface improvement when pairing Sculptra® (PLLA-SCA) with Alastin skincare®: A comparative study. Abstract presented at AMWC 2025; Mar 27-29, 2025; Monaco
Bromée T, et al. A new hyaluronic acid injectable, HASHA, sets new G-prime standards. Abstract presented at AMWC 2025; Mar 27-29, 2025; Monaco
Nikolis A, et al. Effectiveness and Safety of a New Hyaluronic Acid Injectable for Augmentation and Correction of Chin Retrusion. J Drugs Dermatol. 2024;23(4):255–61. doi: 10.36849/JDD.8145
Nkolis A, et al. Hyaluronic acid fillers preserve natural movement and dynamic expression: data from three postmarketing clinical studies. Presented at AMWC 2025; Mar 27-29, 2025; Monaco
Percec, I et al. An Objective, Quantitative, Dynamic Assessment of Hyaluronic Acid Fillers That Adapt to Facial Movement. Plast Reconstr Surg. 2020;145:295e–305e. doi: 10.1097/PRS.0000000000006461
Philipp-Dormston WG, et al. Evaluating Perceived Naturalness of Facial Expression After Fillers to the Nasolabial Folds and Lower Face With Standardized Video and Photography. Dermatol Surg. 2018;44(6):826–32. doi: 10.1097/DSS.0000000000001419
Solish N, et al. Dynamics of hyaluronic acid fillers formulated to maintain natural facial expression. J Cosmet Dermatol. 2019;18(3):738–46. doi: 10.1111/jocd.12961
Sundberg AL and Stahl U. Relabotulinum toxin - a novel, high purity BoNT-A1 in liquid formulation. Presented at: TOXINS 2021; Jan 16-17, 2021; virtual meeting
Do M, et al. Purification process of a complex-free highly purified botulinum neurotoxin type A1 (BoNT-A1) - relabotulinumtoxinA. Presented at: TOXINS 2022; July 27-30, 2022; New Orleans, LA
Shridharani SM, et al. Efficacy and Safety of RelabotulinumtoxinA, a New Ready-to-Use Liquid Formulation Botulinum Toxin: Results From the READY-1 Double-Blind, Randomized, Placebo-Controlled Phase 3 Trial in Glabellar Lines. ASJ. 2024; sjae131
Ablon G, et al. Efficacy and Safety of RelabotulinumtoxinA Liquid Botulinum Toxin in the Treatment of Lateral Canthal Lines: Results From the Phase 3 READY-2 Study. Dermatol Surg. 2024. doi: 10.1097/DSS.0000000000004470
Relfydess®. EU Summary of Product Characteristics
Persson C, et al. Patient and Investigator Treatment Experience with Ready-to-Use AbobotulinumtoxinA Solution Versus Powder BotulinumtoxinA for Treatment of Glabellar Lines. Abstract presented at TOXINS 2024; Jan 17-20, 2024, Berlin
Di Gregorio C. 25+ Years of Experience with the Restylane Portfolio of Injectable Hyaluronic Acid Fillers for Facial Aesthetic Treatment. E-poster presented at AMWC, March 27-29, 2024, Monaco
Nikolis A, et al. The Role of Clinical Examination in Midface Volume Correction Using Hyaluronic Acid Fillers: Should Patients Be Stratified by Skin Thickness? Aesthet Surg J Open Forum. 2020; 2(1):1–12.
Galderma. Data on file. Subject satisfaction (GAIS) – NASHA and OBT Fillers. 2021
Restylane U.S. Instructions For Use. Available online. Accessed January 2025.
Kablik J, et al. Comparative Physical Properties of Hyaluronic Acid Dermal Fillers: Dermatologic Surgery 35, 302–312 (2009).
Narins RS, et al. Persistence of nasolabial fold correction with a hyaluronic acid dermal filler with retreatment: results of an 18-month extension study. Dermatol Surg. 2011;37:644–650
Talarico S, et al. High Patient Satisfaction of a Hyaluronic Acid Filler Producing Enduring Full-Facial Volume Restoration: An 18-Month Open Multicenter Study. Dermatol Surg. 2015;41:1361–1369
Ohrlund A, et al.. Differentiation of NASHA and OBT Hyaluronic Acid Gels According to Strength, Flexibility, and Associated Clinical Significance. JDD. 2024; 23(1), pp.1332-1336
Philipp‐Dormston WG, et al. Perceived naturalness of facial expression after hyaluronic acid filler injection in nasolabial folds and lower face. J Cosmet Dermatol. 2020;19(7):1600-6.
U.S. Food and Drug Administration. Sculptra summary of safety and effectiveness data. Available online. Accessed January 2025.
Galderma. Data on File (MA-46589)
Duracinsky M, et al. Safety of poly-L-lactic acid (New-Fill®) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patients. BMC Infect Dis. 2014;14(474). doi:10.1186/1471233414474
Zhang S and Duan E. Fighting against Skin Aging: The Way from Bench to Bedside. Cell Transpl. 2018;27(5):729-738. doi: 10.1177/0963689717725755
Asius J, et al. Inventors. US patent US 7,731,758 B2.2010. Available online. Accessed January 2025
Morgan P, et al. Product Manufacturing Process for Poly-L-lactic acid (PLLA-SCA). Poster presented at IMCAS World Congress, January 26–28, 2023, Paris, France
Galderma. Data on File (MA-53568)
Shuster S, et al. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol. 1975;93(6):639-43. doi: 10.1111/j.1365-2133.1975.tb05113.x
Goldberg D, et al. Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid. Dermatol Surg. 2013;39:915–22
Zarbafian M, et al. The emerging field of regenerative aesthetics—where we are now. Dermatol Surg. 2022;48: 101–108. doi: 10.1097/DSS.0000000000003239
Waibel J, et al. Gene Analysis of Biostimulators: PLLA-SCA Triggers Regenerative Morphogenesis while CaHA-R Induces Inflammation upon Facial Injection. Poster presented at ASDS 2024, October 17-20, 2024, Orlando, Florida, United States
Waibel J, et al. Bulk RNA-seq Analysis of Poly-L-Lactic Acid (PLLA-SCA) vs Calcium Hydroxyapetite (CaHA-R) Reveals a Novel, Adipocyte Mediated Regenerative Mechanism of Action Unique to PLLA. Poster presented at ASDS 2024 Annual Meeting, October 17-20, 2024, Orlando, Florida, United States
Haddad S, et al. Evaluation of the biostimulatory effects and the level of neocollagenesis of dermal fillers: a review. Int J Dermatol. 2022;61:1284–1288. doi: 10.1111/ijd.16229
Vleggaar D, et al. Consensus recommendations on the use of injectable poly-L-lactic-acid for facial and nonfacial volumization. J Drugs Dermatol. 2014;13(4 Suppl):s44–s51
Fabi S, et al. 24-month clinical trial data on effectiveness and safety after correction of cheek wrinkles using a biostimulatory poly-L-lactic acid injectable implant. Poster presented at AMWC, March 30 - April 1, 2023, Monaco
View source version on businesswire.com: https://www.businesswire.com/news/home/20250319676050/en/
Permalink
https://www.aetoswire.com/en/news/2003202545492
Contacts
For further information:
Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50
Sébastien Cros
Corporate Communications Director
sebastien.cros@galderma.com
+41 79 529 59 85
Emil Ivanov
Head of Strategy, Investor Relations, and ESG
emil.ivanov@galderma.com
+41 21 642 78 12
Jessica Cohen
Investor Relations and Strategy Director
jessica.cohen@galderma.com
+41 21 642 76 43
Brisbane Airport embraces advanced analytics from Cirium Sky Warehouse
LONDON - Tuesday, 18. March 2025
Queensland’s major airport pioneers data consolidation in the cloud to drive operational efficiency
(BUSINESS WIRE)--Brisbane Airport (BNE), which serves as the major gateway to Queensland, has partnered with aviation analytics firm, Cirium, to become one of the first airports to integrate Cirium Sky Warehouse, a data-driven cloud platform, into its modernisation efforts.
Cirium’s advanced data and analytics will be seamlessly integrated with Brisbane Airport’s business systems. This integration will support enhanced capacity planning, resource allocation, and operations analysis.
Jeremy Bowen, Cirium CEO, commented: "We are delighted to support Brisbane Airport’s transformative investment to revolutionise its passenger experience and meet future travel demand.
“Integrating Cirium data and analytics through the Cirium Sky Warehouse will help the airport to consolidate and accelerate digitization, leading to improved decision-making and operational performance.
"Our data will be a crucial asset in driving efficiency and elevating the traveler experience at Brisbane Airport."
Ryan Both, Brisbane Airport Executive General Manager Aviation said: “Accessing Cirium’s schedules data through Cirium Sky Warehouse enables advanced automation, marking a critical step in Brisbane Airport’s digital transformation project.”
“The schedules data plays a critical role in creating and executing more accurate flight schedules, planning for future events and fluctuations in air traffic, gaining more comprehensive insights, and making decisions for business growth. This will lead to numerous improvements around efficiency, sustainability and passenger experience.”
“Embracing a cloud-based data integration approach also means we will significantly reduce the time spent internally on data and ultimately drive cost efficiencies.”
Brisbane Airport is currently undergoing a transformation program known as Future BNE, which includes 150 projects over a 10-year period, focusing on upgrades to the airport’s domestic and international terminals, as well as planning for a third terminal, ahead of the city hosting the 2032 Olympics.
This first phase modernization will support an improved experience for the almost 25 million passengers currently passing through its terminals and the additional 10 million expected over the coming decade.
The Cirium Sky Warehouse delivers the highest quality aviation data and analytics in one accessible data cloud, aligning seamlessly with Brisbane Airport’s digital transformation objectives. While the airport will initially leverage schedules data, a wealth of other data can be accessed and integrated from Cirium Sky Warehouse including flight, traffic, fleet, fares, weather, and CO2 emissions.
By leveraging the power of Cirium’s data cloud, Brisbane Airport joins global major airlines, fuel supply companies, aviation financiers, and more in enhancing its planning, operational efficiency and growth opportunities.
Notes to editors
To find out more about the Cirium Sky Warehouse, click here.
About Cirium
Cirium® is the world’s most trusted source of aviation analytics, delivering powerful data and cutting-edge analytics to empower a wide spectrum of industry players. Equipping airlines, airports, travel enterprises, aircraft manufacturers, and financial entities, the company provides the clarity and intelligence needed to optimise operations, make informed decisions and accelerate revenue growth. Cirium® is part of LexisNexis® Risk Solutions, a RELX business, which provides information-based analytics and decision tools for professional and business customers. The shares of RELX PLC are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX. For further information please follow Cirium on LinkedIn or visit cirium.com.
About Brisbane Airport
BNE is the third-largest airport in Australia by passenger numbers, with 24 million passengers travelling through the airport annually. BNE contributes $4.7 billion GDP annually, with 1 in 70 Queensland jobs enabled by BNE and benefits provided range of key industries such as tourism, resources and international education. BNE is the largest airport in Australia by land size, covering 2,700 hectares of land used for aviation, property development and consumer businesses, which employ over 20,000 people. In 2025 it celebrates 100 years of operation.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250317052819/en/
Permalink
https://www.aetoswire.com/en/news/20250317052819r1
Contacts
For Cirium media inquiries please contact media@cirium.com
Queensland’s major airport pioneers data consolidation in the cloud to drive operational efficiency
(BUSINESS WIRE)--Brisbane Airport (BNE), which serves as the major gateway to Queensland, has partnered with aviation analytics firm, Cirium, to become one of the first airports to integrate Cirium Sky Warehouse, a data-driven cloud platform, into its modernisation efforts.
Cirium’s advanced data and analytics will be seamlessly integrated with Brisbane Airport’s business systems. This integration will support enhanced capacity planning, resource allocation, and operations analysis.
Jeremy Bowen, Cirium CEO, commented: "We are delighted to support Brisbane Airport’s transformative investment to revolutionise its passenger experience and meet future travel demand.
“Integrating Cirium data and analytics through the Cirium Sky Warehouse will help the airport to consolidate and accelerate digitization, leading to improved decision-making and operational performance.
"Our data will be a crucial asset in driving efficiency and elevating the traveler experience at Brisbane Airport."
Ryan Both, Brisbane Airport Executive General Manager Aviation said: “Accessing Cirium’s schedules data through Cirium Sky Warehouse enables advanced automation, marking a critical step in Brisbane Airport’s digital transformation project.”
“The schedules data plays a critical role in creating and executing more accurate flight schedules, planning for future events and fluctuations in air traffic, gaining more comprehensive insights, and making decisions for business growth. This will lead to numerous improvements around efficiency, sustainability and passenger experience.”
“Embracing a cloud-based data integration approach also means we will significantly reduce the time spent internally on data and ultimately drive cost efficiencies.”
Brisbane Airport is currently undergoing a transformation program known as Future BNE, which includes 150 projects over a 10-year period, focusing on upgrades to the airport’s domestic and international terminals, as well as planning for a third terminal, ahead of the city hosting the 2032 Olympics.
This first phase modernization will support an improved experience for the almost 25 million passengers currently passing through its terminals and the additional 10 million expected over the coming decade.
The Cirium Sky Warehouse delivers the highest quality aviation data and analytics in one accessible data cloud, aligning seamlessly with Brisbane Airport’s digital transformation objectives. While the airport will initially leverage schedules data, a wealth of other data can be accessed and integrated from Cirium Sky Warehouse including flight, traffic, fleet, fares, weather, and CO2 emissions.
By leveraging the power of Cirium’s data cloud, Brisbane Airport joins global major airlines, fuel supply companies, aviation financiers, and more in enhancing its planning, operational efficiency and growth opportunities.
Notes to editors
To find out more about the Cirium Sky Warehouse, click here.
About Cirium
Cirium® is the world’s most trusted source of aviation analytics, delivering powerful data and cutting-edge analytics to empower a wide spectrum of industry players. Equipping airlines, airports, travel enterprises, aircraft manufacturers, and financial entities, the company provides the clarity and intelligence needed to optimise operations, make informed decisions and accelerate revenue growth. Cirium® is part of LexisNexis® Risk Solutions, a RELX business, which provides information-based analytics and decision tools for professional and business customers. The shares of RELX PLC are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX. For further information please follow Cirium on LinkedIn or visit cirium.com.
About Brisbane Airport
BNE is the third-largest airport in Australia by passenger numbers, with 24 million passengers travelling through the airport annually. BNE contributes $4.7 billion GDP annually, with 1 in 70 Queensland jobs enabled by BNE and benefits provided range of key industries such as tourism, resources and international education. BNE is the largest airport in Australia by land size, covering 2,700 hectares of land used for aviation, property development and consumer businesses, which employ over 20,000 people. In 2025 it celebrates 100 years of operation.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250317052819/en/
Permalink
https://www.aetoswire.com/en/news/20250317052819r1
Contacts
For Cirium media inquiries please contact media@cirium.com
Arzan Wealth Advises on the Strategic Acquisition of a Premier Radiology Center Portfolio in Long Island, New York
Dubai, United Arab Emirates - Thursday, 20. March 2025 AETOSWire
Arzan Wealth (DIFC) Limited (‘Arzan Wealth’), a Dubai-based advisory firm regulated by the Dubai Financial Services Authority, is delighted to announce its successful advisory role in the acquisition of a portfolio of three outpatient imaging centers in Nassau County, Long Island, New York, USA.
The centers operate under the name Lenox Hill Radiology, a wholly owned subsidiary of RadNet (Nasdaq: RDNT | S&P: B+), one of the largest outpatient diagnostic imaging providers in the U.S. These state-of-the-art facilities, totaling 29,283 square feet, are strategically located along major thoroughfares, providing excellent visibility and easy access for patients. Fully leased for 16 years with a 3% annual indexation, the centers are operated by one of the region's most dominant radiology practices.
Arzan Wealth provided comprehensive advisory services throughout the structuring and acquisition process, ensuring a seamless transaction. The firm will continue to advise on the investment during the holding period, which is expected to generate an average net cash yield payment of 8.5% over the anticipated 5-year holding period.
Muhannad Abulhasan, CEO of Arzan Wealth, commented:
"We are excited to have successfully facilitated the acquisition of this strategic portfolio of outpatient imaging centers. This investment aligns with our commitment to identifying high-quality, income-generating assets for our clients. The portfolio's long-term leases and strong tenant profile provide stability, while the projected cash yield of 8.5% over the next five years offers an attractive current income portion of the total return. We continue to prioritize prudent risk management, ensuring that our clients' wealth is safeguarded while generating robust financial outcomes for the long term."
Notes to Editors
About Arzan Wealth (DIFC) Limited
Arzan Wealth is an investment advisory firm registered at the Dubai International Financial Centre (DIFC), and is regulated by the Dubai Financial Services Authority (DFSA). Arzan Wealth currently advises various professional clients on real estate, private equity and other investments with a total value of assets advised around US$ 2.57 Billion. Arzan Wealth focuses on arranging yielding investments in major global markets, as well as bespoke investments that meet the requirements of specific clients.
Past or projected performance is not necessarily a reliable indicator of future results. Arzan Wealth (DIFC) Limited accepts no liability for any loss arising from the use of this document or its contents or otherwise arising in connection therewith.
Permalink
https://www.aetoswire.com/en/news/2003202545487
Contacts
For further information contact:
Ahmad AlSabbrei
Head of Investment Operations
a.alsabbrei@arzanwealth.com
+965 9988 8624
Experian Assistant Wins 2025 FinTech Breakthrough Award for Analytics Innovation
Agentic AI-powered virtual assistant offers 24/7 analytics and modeling expertise, helps slash model-development times for financial institutions
(BUSINESS WIRE)--Experian, a leading global data and technology company, today announced that Experian Assistant, an agentic AI-powered solution that greatly accelerates the data-modeling lifecycle, has won the 2025 FinTech Breakthrough Award for Analytics Innovation. For the second consecutive year, Experian received this prestigious award that recognizes those “who are dedicated to reshaping the FinTech industry and improving people’s lives through innovative technologies.”
Experian Assistant enables financial institutions to perform data exploration, build and deploy models, monitor their performance, and increase speed to market to launch new offerings. Integrated with Experian Ascend Platform™, the solution greatly accelerates the modeling lifecycle, slashing model-development times from months to days and — in some cases — hours.
“To stay ahead of their competition, financial institutions need a solution to quickly go from ideas to data and into production,” said Shri Santhanam, Executive Vice President and General Manager of Software, Platforms, and AI, Experian North America. “Like having an analytics and modeling expert by your side 24x7, Experian Assistant provides immediate responses to users’ questions, enhances model transparency, and helps quickly parse through multiple model iterations by selecting optimal modeling features along with coding and deployment support.”
The world’s largest financial Institutions use Experian’s Ascend Platform and – in close collaboration with several customers – Experian Assistant was developed to offer them a deeper understanding of credit data and provide best practices on how to optimally use analytics. It enables those institutions to broaden their scope of data and deploy advanced, agentic AI to effectively score a larger number of consumers. This improves their accuracy and inclusivity, and aligns with Experian's mission of fostering greater financial equity.
Experian Assistant advances regulatory compliance through automated model risk documentation, identity and fraud management, risk assessment and transaction monitoring.
This year’s 9th annual awards program received more than 4,500 nominations from all over the world. For more information on the 2025 FinTech Breakthrough Awards, visit: https://fintechbreakthrough.com/.
About Experian
Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realize their financial goals and help them to save time and money.
We operate across a range of markets, from financial services to healthcare, automotive, agribusiness, insurance, and many more industry segments.
We invest in talented people and new advanced technologies to unlock the power of data and innovate. As a FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 22,500 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.
Experian and the Experian marks used herein are trademarks or registered trademarks of Experian and its affiliates. Other product and company names mentioned herein are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250320296728/en/
Permalink
https://www.aetoswire.com/en/news/2003202545517
Contacts
Michael Troncale
Experian Public Relations
+1 714 830 5462
michael.troncale@experian.com
Thursday, March 20, 2025
SoftBank Group to Acquire Ampere Computing
TOKYO & SANTA CLARA, Calif. - Thursday, 20. March 2025
(BUSINESS WIRE)--SoftBank Group Corp. (TSE: 9984, “SoftBank Group”) today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere’s lead investors – Carlyle (NASDAQ: CG) and Oracle Corp. (NYSE: ORCL) – are selling their respective positions in Ampere.
As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group’s capabilities in key areas and accelerate its growth initiatives.
“The future of Artificial Super Intelligence requires breakthrough computing power,” said Masayoshi Son, Chairman and CEO of SoftBank Group Corp. “Ampere’s expertise in semiconductors and high-performance computing will help accelerate this vision, and deepens our commitment to AI innovation in the United States.”
“With a shared vision for advancing AI, we are excited to join SoftBank Group and partner with its portfolio of leading technology companies,” said Renee James, Founder and CEO of Ampere. “This is a fantastic outcome for our team, and we are excited to drive forward our AmpereOne® roadmap for high performance Arm processors and AI.”
Founded in Silicon Valley in 2018 with an initial focus on cloud-native computing, Ampere has since expanded into sustainable AI compute. The company has multiple products for a spectrum of cloud workloads from the edge to the cloud data center.
Transaction Details
Under the terms of the agreement, SoftBank will acquire Ampere for $6.5 billion in cash. The transaction is subject to customary closing conditions, including regulatory approvals, and is expected to close in the second half of 2025. Ampere’s headquarters will remain in Santa Clara, CA.
About SoftBank Group
The SoftBank Group invests in breakthrough technology to improve the quality of life for people around the world. The SoftBank Group is comprised of SoftBank Group Corp. (TOKYO: 9984), an investment holding company that includes stakes in AI, smart robotics, IoT, telecommunications, internet services, and clean energy technology providers, as well as a majority stake in Arm, which is building the future of computing; and the SoftBank Vision Funds, which are investing to help transform industries and shape new ones. To learn more, please visit https://group.softbank/en.
About Ampere
Ampere is a semiconductor design company focused on high-performance, energy efficient, sustainable AI Compute based on the Arm compute platform. To learn more, please visit https://amperecomputing.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250319660334/en/
Permalink
https://www.aetoswire.com/en/news/2003202545491
Contacts
Media contacts:
Ampere
press@amperecomputing.com
SoftBank Group
softbank@fgsglobal.com
Venture Global Receives Non-FTA Export Authorization for CP2 LNG
U.S. Department of Energy grants CP2 LNG approval to export to non-FTA countries
(BUSINESS WIRE) -- Today, Venture Global received approval from the U.S. Department of Energy to export liquefied natural gas (LNG) to non-FTA countries for its third project, CP2 LNG, located in Cameron Parish, Louisiana. Venture Global CEO Mike Sabel issued the following statement:
“CP2 LNG is a vital project for the U.S. economy, balance of trade, and global energy security. We are grateful for the Trump Administration’s return to regular order and regulatory certainty that will allow us to further expand U.S. LNG exports, which have consistently been found to be in the public interest across multiple Administrations. This will enable us to provide our allies around the world with American LNG in just a few years and for decades to come.”
Earlier this month, Venture Global announced that it has launched the FID process for CP2 LNG. To date, the initial phase of CP2 LNG has been sold through 20-year sales and purchase agreements with ExxonMobil, Chevron, JERA, New Fortress Energy, INPEX, China Gas, SEFE and EnBW. Venture Global is in active discussions for the remaining capacity and has launched significant off site construction of the project while it has awaited project authorizations from U.S. regulators.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250319226258/en/
Permalink
https://www.aetoswire.com/en/news/1903202545485
Contacts
Investor Contact
Michael Pasquarello
IR@ventureglobalLNG.com
Media Contact
Shaylyn Hynes
press@ventureglobalLNG.com
Fujirebio Enhances Supply Chain Operations with Kinaxis
OTTAWA, Ontario -
Japanese biotech leader adopts orchestration to more rapidly respond to demand fluctuations
(BUSINESS WIRE) -- Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced that Fujirebio Inc., a Japanese multinational biotechnology company, is using Kinaxis and its AI-powered supply chain orchestration platform Maestro™ to enhance and optimize its supply chain operations.
Fujirebio Inc., a consolidated subsidiary of Fujirebio Holdings Inc., is a global leader in the development, manufacturing and sales of clinical diagnostic reagents and testing equipment. Fujirebio is currently focused on strengthening and expanding its Contract Development and Manufacturing Organization (CDMO) by leveraging high-quality raw materials in the immunology field and advanced reagent development technologies.
To accelerate the company’s growth, Fujirebio needed to strategically link and synchronize its entire supply chain process, which spans raw material production to final product shipment and encompasses a multi-layered and complex set of operations.
“The adoption of Kinaxis is central to building a more flexible and efficient supply chain model,” said Kazuya Saito, division head of SCM division, corporate SCM division at Fujirebio Inc. “This will enable faster strategic decision-making and accelerate our efforts toward transforming our business structure. At the same time, we aim to provide new value to the healthcare industry.”
By implementing the Maestro platform, Fujirebio is working to orchestrate demand, production and procurement planning across its supply chain, enabling fast planning simulations. This will also facilitate the establishment of an S&OP (Sales and Operations Planning) process that accelerates strategic decision-making based on financial data.
“In the healthcare industry, there is a need for advanced planning management that considers manufacturing constraints and manages inventory in both quantity and financial terms. We are pleased to support Fujirebio as they advance strategic decision-making through the use of simulations,” said Phillip Teschemacher, president of APAC at Kinaxis.
To learn more about Kinaxis and its supply chain orchestration solutions, please visit Kinaxis.com.
About Fujirebio
Fujirebio, a member of H.U. Group Holdings Inc., is a global R&D-driven company constantly developing new in vitro diagnostics testing technologies and unique biomarkers with high clinical value. Our group mission is to create new value in healthcare and thereby contribute to human health and the future of medical care. Our global teams located in Japan, Asia, Europe, and the US focus on delivering products with the highest quality standards to our customers and partners. We value partnerships with other leading companies in the industry, sharing knowledge, capabilities, and critical materials to supply, develop, or manufacture diagnostic solutions on a wide variety of platforms. For more information about Fujirebio, please visit www.fujirebio.com.
About Kinaxis
Kinaxis is a global leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them, in service of humanity. Our powerful, AI-infused supply chain orchestration platform, Maestro™, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain — from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn.
Source: Kinaxis Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250319567981/en/
Permalink
https://www.aetoswire.com/en/news/1903202545479
Contacts
Media Relations
Matt Tatham | Kinaxis
mtatham@kinaxis.com
+1 917.446.7227
Investor Relations
Rick Wadsworth | Kinaxis
rwadsworth@kinaxis.com
+1 613-907-7613
Fujirebio Europe Launches the INNO-LiPA® HCV 2.0 Genotyping Assay, an Efficient Aid to Personalized HCV Therapy
GENT, Belgium
(BUSINESS WIRE)--Fujirebio Europe today announced the availability* of the INNO-LiPA HCV 2.0 Genotyping assay. The product, previously distributed by Siemens Healthcare Diagnostics Inc. under the name VERSANT HCV Genotype 2.0, is a line probe assay, for in vitro diagnostic use, designed for the qualitative detection and identification of Hepatitis C virus (HCV) genotypes 1 to 6 and subtypes a and b of genotype 1 in human serum or EDTA plasma samples. Additional subtype information is available in a majority of cases.
“At Fujirebio we have been pioneering molecular testing solutions since the 1990’s with our high quality LiPA platform,” says Christiaan De Wilde, CEO at Fujirebio Europe. “The historical VERSANT HCV Genotype 2.0 Assay (LiPA) served as an efficient aid to personalized HCV therapy, and we are very pleased to maintain the availability of the test, now officially a part of our INNO-LiPA product range. We would like to extend our gratitude to all INNO-LiPA customers for their continued trust.”
About Hepatitis C virus
Hepatitis C virus is one of the leading causes of chronic liver disease, cirrhosis, and hepatocellular carcinoma (primary liver cancer), resulting in major global public health concerns. The HCV infection is unevenly distributed worldwide, with variations in prevalence across and within countries.1
Globally, an estimated 50 million people have chronic hepatitis C virus infection, with about 1.0 million new infections occurring per year. WHO estimated that in 2022, approximately 242 000 people died from hepatitis C, mostly from cirrhosis and hepatocellular carcinoma. Early detection and treatment can prevent serious liver damage and improve long-term health.2
About INNO-LiPA HCV 2.0 Genotyping
INNO-LiPA HCV 2.0 Genotyping products are IVDR-marked. The available* products are:
INNO-LiPA HCV 2.0 Genotyping <20T,CE> (Cat# 81547)
INNO-LiPA HCV 2.0 Amp <20T,CE> (Cat# 81548)
INNO-LiPA HCV 2.0 Control <3T,CE> (Cat# 81549)
LiRAS® for LiPA HCV v4 (Cat# 15228)
The assay is available in a size of 20T. The test can be performed manually or automated (on the TENDIGO™ (Cat# 80412) instrument) and is not intended to be used as a screening test for HCV or as a diagnostic test to confirm the presence of HCV.
Visit www.fujirebio.com for more information about this product.
* Please contact Fujirebio for further information about the local availability of the test.
References:
Guntipalli P, Pakala R, Kumari Gara S, Ahmed F, Bhatnagar A, Endaya Coronel MK, Razzack AA, Solimando AG, Thompson A, Andrews, K, Enebong Nya G, Ahmad S, Ranaldo R, Cozzolongo R, Shahini E. Worldwide prevalence, genotype distribution and management of hepatitis C. Acta Gastroenterol Belg. 2021 Oct-Dec;84(4):637-656. doi: 10.51821/84.4.015. PMID: 34965046.
https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
View source version on businesswire.com: https://www.businesswire.com/news/home/20250317463658/en/
Permalink
https://www.aetoswire.com/en/news/20250317463658r1
Contacts
For media:
Public Relations Section, Public Relations/Sustainability Department,
H.U. Group Holdings, Inc..
Phone: +81-3-6279-0884
E-mail: pr@hugp.com
Christiaan De Wilde
CEO Fujirebio Europe
Phone: +32 9329 1703
For investors and analysts:
IR/SR Dept.
Phone: +81-3-5909-3337
E-mail: ir@hugp.com
Accelera hosts Spanish Prime Minister and industry leaders for tour and meeting at Guadalajara electrolyzer facility
GUADALAJARA, Spain - Wednesday, 19. March 2025
(BUSINESS WIRE)--Accelera™ by Cummins, the zero-emissions business segment of Cummins Inc. [NYSE: CMI], hosted Spanish Prime Minister Pedro Sánchez and other government officials at its state-of-the-art electrolyzer manufacturing facility in Guadalajara, Castilla-la Mancha, Spain. The visit highlighted Accelera's important role in enabling the European Union (EU) and Spain's energy transition toward a sustainable future. Following Prime Minister Sánchez’s visit, Accelera held a meeting with top industry executives to explore opportunities for advancing the Spanish green hydrogen market together.
The Government of Spain is committed to the green transition, with green hydrogen as one of its pillars. The decisive policies promoted by the Executive have allowed 20% of green hydrogen projects in Europe to be promoted in Spain.
Prime Minister Sánchez toured the 260,000 square-foot proton exchange membrane (PEM) electrolyzer manufacturing facility, one of the largest in Spain, and met with Accelera employees to celebrate their work in building the nation’s green hydrogen economy. The energy-efficient electrolyzer facility began production in April 2024 and has created 91 highly skilled jobs, with the potential for more as production expands.
Accelera is one of Spain’s leading electrolyzer manufacturers, and with one of the largest economies in the EU and its low cost of renewable energy, the country offers a strong environment for the expansion of hydrogen and electrolyzer production and export.
"We are honored to have Prime Minister Pedro Sánchez visit Accelera’s electrolyzer manufacturing plant in Guadalajara,” said Amy Davis, President of Accelera. “Our partnership with the Spanish government is key to developing the necessary infrastructure to continue scaling and innovating hydrogen technologies to achieve a zero-emissions future. Together, we are committed to advancing Spain and the EU’s green energy transition.”
Accelera recently announced its largest electrolyzer project to date – a 100-megawatt (MW) system for bp’s green hydrogen plant in Lingen, Germany – and production for the electrolyzer system is underway at the facility in Guadalajara. With an immediate 500MW of capacity, scalable to 1-gigawatt (GW), Accelera has plans to increase onsite manufacturing in the future, bringing more hydrogen production to Spain and further establishing the country as a hydrogen industrial hub in Europe.
After the Prime Minister’s visit, Accelera hosted a high-level meeting with Spain’s green hydrogen leaders to explore collaboration opportunities to accelerate Spain's position as Europe's hydrogen hub and meet the ambitious decarbonization targets set by both the country and the EU. This dialogue focused on establishing a framework for ongoing industry partnership to maximize Spain's ability to be a leader in green hydrogen production and technology development.
During the discussions, participants emphasized the importance of domestic electrolyzer production in Spain, including Accelera’s plant in Guadalajara. This production is crucial not only for reaching Spain’s target of 12 GW of installed electrolyzers, but also for creating jobs and strengthening Spain’s industrial base.
Attendees included:
Olvido Moraleda, President of bp Spain and Vice President of bp group
Arturo Gonzalo Aizpiri, CEO of Enagás
Millán García-Tola, Global Hydrogen Director of Iberdrola
José Manuel Martínez, CTO of Moeve
Amy Davis, President of Accelera by Cummins
Andreas Lippert, Vice President of Electrolyzers for Accelera by Cummins
Electrolyzers leverage renewable energy sources to produce green hydrogen, which is vital for accelerating the clean energy transition. Accelera is a leader in large-scale hydrogen production using PEM electrolysis and has deployed more than 600 electrolyzer units worldwide, powering some of the most advanced PEM electrolyzer systems operating globally. This includes a 20MW facility in Quebec, Canada, and a 25MW system in Florida, U.S.
###
About Accelera™ by Cummins
Accelera by Cummins provides a diverse portfolio of zero-emissions solutions for the world’s most economically vital industries, empowering them to accelerate the transition to a sustainable future. Accelera, a business segment of Cummins Inc., is both a components supplier and integrator, focused on batteries, e-axles, traction systems, integrated powertrain solutions, hydrogen fuel cells, and electrolyzers. Accelera currently has operations in North America, across Europe, and in China.
Cummins, a global power solutions leader, is a corporation of complementary business segments that design, manufacture, distribute, and service a broad portfolio of power solutions. Headquartered in Columbus, Indiana (U.S.), Cummins has approximately 69,900 employees and earned $3.9 billion on sales of $34.1 billion in 2024. It operates a robust distribution and support network in more than 190 countries and territories.
To learn more about Accelera by Cummins, visit accelerazero.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250318352856/en/
Permalink
https://www.aetoswire.com/en/news/20250318352856r1
Contacts
Melinda Koski – Director, External Communications
melinda.koski@cummins.com
+1-812-377-0500
(BUSINESS WIRE)--Accelera™ by Cummins, the zero-emissions business segment of Cummins Inc. [NYSE: CMI], hosted Spanish Prime Minister Pedro Sánchez and other government officials at its state-of-the-art electrolyzer manufacturing facility in Guadalajara, Castilla-la Mancha, Spain. The visit highlighted Accelera's important role in enabling the European Union (EU) and Spain's energy transition toward a sustainable future. Following Prime Minister Sánchez’s visit, Accelera held a meeting with top industry executives to explore opportunities for advancing the Spanish green hydrogen market together.
The Government of Spain is committed to the green transition, with green hydrogen as one of its pillars. The decisive policies promoted by the Executive have allowed 20% of green hydrogen projects in Europe to be promoted in Spain.
Prime Minister Sánchez toured the 260,000 square-foot proton exchange membrane (PEM) electrolyzer manufacturing facility, one of the largest in Spain, and met with Accelera employees to celebrate their work in building the nation’s green hydrogen economy. The energy-efficient electrolyzer facility began production in April 2024 and has created 91 highly skilled jobs, with the potential for more as production expands.
Accelera is one of Spain’s leading electrolyzer manufacturers, and with one of the largest economies in the EU and its low cost of renewable energy, the country offers a strong environment for the expansion of hydrogen and electrolyzer production and export.
"We are honored to have Prime Minister Pedro Sánchez visit Accelera’s electrolyzer manufacturing plant in Guadalajara,” said Amy Davis, President of Accelera. “Our partnership with the Spanish government is key to developing the necessary infrastructure to continue scaling and innovating hydrogen technologies to achieve a zero-emissions future. Together, we are committed to advancing Spain and the EU’s green energy transition.”
Accelera recently announced its largest electrolyzer project to date – a 100-megawatt (MW) system for bp’s green hydrogen plant in Lingen, Germany – and production for the electrolyzer system is underway at the facility in Guadalajara. With an immediate 500MW of capacity, scalable to 1-gigawatt (GW), Accelera has plans to increase onsite manufacturing in the future, bringing more hydrogen production to Spain and further establishing the country as a hydrogen industrial hub in Europe.
After the Prime Minister’s visit, Accelera hosted a high-level meeting with Spain’s green hydrogen leaders to explore collaboration opportunities to accelerate Spain's position as Europe's hydrogen hub and meet the ambitious decarbonization targets set by both the country and the EU. This dialogue focused on establishing a framework for ongoing industry partnership to maximize Spain's ability to be a leader in green hydrogen production and technology development.
During the discussions, participants emphasized the importance of domestic electrolyzer production in Spain, including Accelera’s plant in Guadalajara. This production is crucial not only for reaching Spain’s target of 12 GW of installed electrolyzers, but also for creating jobs and strengthening Spain’s industrial base.
Attendees included:
Olvido Moraleda, President of bp Spain and Vice President of bp group
Arturo Gonzalo Aizpiri, CEO of Enagás
Millán García-Tola, Global Hydrogen Director of Iberdrola
José Manuel Martínez, CTO of Moeve
Amy Davis, President of Accelera by Cummins
Andreas Lippert, Vice President of Electrolyzers for Accelera by Cummins
Electrolyzers leverage renewable energy sources to produce green hydrogen, which is vital for accelerating the clean energy transition. Accelera is a leader in large-scale hydrogen production using PEM electrolysis and has deployed more than 600 electrolyzer units worldwide, powering some of the most advanced PEM electrolyzer systems operating globally. This includes a 20MW facility in Quebec, Canada, and a 25MW system in Florida, U.S.
###
About Accelera™ by Cummins
Accelera by Cummins provides a diverse portfolio of zero-emissions solutions for the world’s most economically vital industries, empowering them to accelerate the transition to a sustainable future. Accelera, a business segment of Cummins Inc., is both a components supplier and integrator, focused on batteries, e-axles, traction systems, integrated powertrain solutions, hydrogen fuel cells, and electrolyzers. Accelera currently has operations in North America, across Europe, and in China.
Cummins, a global power solutions leader, is a corporation of complementary business segments that design, manufacture, distribute, and service a broad portfolio of power solutions. Headquartered in Columbus, Indiana (U.S.), Cummins has approximately 69,900 employees and earned $3.9 billion on sales of $34.1 billion in 2024. It operates a robust distribution and support network in more than 190 countries and territories.
To learn more about Accelera by Cummins, visit accelerazero.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250318352856/en/
Permalink
https://www.aetoswire.com/en/news/20250318352856r1
Contacts
Melinda Koski – Director, External Communications
melinda.koski@cummins.com
+1-812-377-0500
NetApp Storage Now Validated for NVIDIA DGX SuperPOD, NVIDIA Cloud Partners, and NVIDIA-Certified Systems
SAN JOSE, Calif. - Wednesday, 19. March 2025 AETOSWire
NetApp’s rich data management capabilities accelerate AI innovation for customers
(BUSINESS WIRE)--NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced that NVIDIA has validated high-performance NetApp enterprise storage systems with NetApp ONTAP® for environments powering AI training and inferencing. For the first time, with NetApp, customers can now get the benefits of validated configurations and architectures for NVIDIA—including NVIDIA DGX SuperPOD, NVIDIA Cloud Partners, and NVIDIA-Certified Storage—combined with the rich and mature data management services in NetApp ONTAP critical for building AI factories.
These certifications ready NetApp to tap the NVIDIA AI Data Platform reference design for NetApp ONTAP to advance storage infrastructure with AI agents for reasoning model inference workloads, powered by NVIDIA accelerated computing, networking, and software.
“NetApp and NVIDIA are longstanding technology partners, jointly serving hundreds of customers for AI model training and inferencing,” said Jonsi Stefansson, Senior Vice President and Chief Technology Officer at NetApp. “NetApp is committed to helping our customers navigate the era of intelligence by taking control of their data without silos. Harnessing AI to drive innovation and operational excellence is more than a technology problem. It’s a data strategy problem. By collaborating with NVIDIA, NetApp is positioned to be the leader in providing intelligent data infrastructure for AI factories, helping customers execute a data strategy that can carry them into the future.”
To compete in the era of intelligence, generating data-driven insights is now a requirement of doing business. Many businesses have found that they need to rethink their data management strategies to adapt to this new reality. Adopting an intelligent data infrastructure framework gives businesses the power to manipulate their data securely without silos in every environment to extract critical insights and automate operations with AI. By collaborating with NVIDIA to certify and validate its data storage and management capabilities, NetApp is making it easier for companies to leverage intelligent data infrastructure to drive AI innovation.
“Together, NetApp and NVIDIA are making it possible to leverage the full potential of AI,” said Charlie Boyle, Vice President, DGX Platforms at NVIDIA. “By integrating NetApp's advanced data management capabilities with the NVIDIA AI Data Platform, DGX SuperPOD, and NVIDIA reference architectures, enterprises and cloud providers can deploy a seamless, high-performance environment for AI model training and inferencing applications.”
At NVIDIA GTC 2025, NetApp is announcing updates and certifications for its portfolio supporting AI innovation, including:
NetApp AFF A90 Validated for NVIDIA DGX SuperPOD: NetApp AFF A90 enterprise storage systems with NetApp ONTAP are now validated for NVIDIA DGX SuperPOD. Bringing the most secure storage on the planet to DGX SuperPOD deployments gives customers the enterprise data management capabilities and scalable multi-tenancy they need to develop and operate high-performance AI factories and deploy agentic AI while eliminating data silos.
NetApp AFF A90 Certified as High-Performance Storage for NVIDIA Cloud Partners with NVIDIA HGX Systems: With certification to support NVIDIA Cloud Partner (NCP) Reference Architectures for high-performance storage with NVIDIA HGX B200 and HGX H200 systems, NetApp will be able to act as the underlying storage for NVIDIA Cloud Partners to power the largest AI-as-a-service providers. NetApp AFF A90 systems deliver the powerful performance necessary to deliver transformational AI and data services across secure multi-tenant environments, enabling NCPs to deliver scalable AI infrastructure to their customers.
NetApp AIPod Certified for Enterprise Storage with New NVIDIA-Certified Storage Program: NetApp AIPod has achieved the new NVIDIA-Certified Storage designation to support NVIDIA Enterprise Reference Architectures with high-performance storage. NetApp is now certified to provide enterprise-grade storage for NVIDIA-Certified Systems across a wide range of AI workloads to speed accelerated computing platforms—from NVIDIA L40S to NVIDIA HGX H200 supercomputers—to ensure AI infrastructure performance, scalability, quality, efficiency and reliability. Additionally, NetApp is releasing a new version of NetApp AIPod with Lenovo including the NVIDIA AI Enterprise software platform, which delivers increased flexibility for customers deploying AI infrastructure for inferencing and fine-tuning. This simplified architecture provides the foundation to capitalize on the generative and agentic AI opportunity without investing in dedicated data science resources.
NetApp delivers the high-performance storage companies need to turbocharge critical workloads like AI. Paired with the scale-out and data unification capabilities of NetApp ONTAP—trusted by tens of thousands of customers with existing unstructured data estates—customers have the tools they need to grow AI-workloads to match their pace of innovation.
To explore these new capabilities and learn how NetApp can help drive AI innovation with NVIDIA, visit the NetApp booth #318 at NVIDIA GTC in San Jose from March 17-21, 2025.
Additional Resources
NetApp HPC Solutions: AI Performance on High
Powering the Next Generation of AI Infrastructure
NetApp Fuels Future of Agentic AI Reasoning Solutions with NVIDIA AI Data Platform
About NetApp
NetApp is the intelligent data infrastructure company, combining unified data storage, integrated data, operational and workload services to turn a world of disruption into opportunity for every customer. NetApp creates silo-free infrastructure, harnessing observability and AI to enable the industry’s best data management. As the only enterprise-grade storage service natively embedded in the world’s biggest clouds, our data storage delivers seamless flexibility. In addition, our data services create a data advantage through superior cyber resilience, governance, and application agility. Our operational and workload services provide continuous optimization of performance and efficiency for infrastructure and workloads through observability and AI. No matter the data type, workload, or environment, with NetApp you can transform your data infrastructure to realize your business possibilities. Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250318565753/en/
Permalink
https://www.aetoswire.com/en/news/54225236
Contacts
Media Contact:
Kenya Hayes
NetApp
kenya.hayes@netapp.com
Investor Contact:
Kris Newton
NetApp
kris.newton@netapp.com
NetApp Fuels Future of Agentic AI Reasoning Solutions with NVIDIA AI Data Platform
NVIDIA-powered data agents coming to NetApp ONTAP will speed inference
(BUSINESS WIRE)--NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced it is advancing the state of the art in agentic AI with intelligent data infrastructure that taps the NVIDIA AI Data Platform reference design. By collaborating with NVIDIA, NetApp is enabling businesses to better leverage their data to fuel AI reasoning inference.
In the era of intelligence, businesses need to rethink their data strategies to turn rapidly growing data estates into competitive assets that empower them to agilely navigate their business environment. By adopting an Intelligent Data Infrastructure framework, businesses will be able to operate under a unified vision that integrates metadata cataloging, automation, and hybrid cloud capabilities to eliminate siloes and deliver actionable insights at every stage of the AI pipeline.
Together, NetApp ONTAP® and the NVIDIA AI Data Platform enable businesses to navigate the era of intelligence by building distributed systems that unlock the full value of business data to fuel data-driven actions. Built on NVIDIA’s expertise in AI workflow optimization, the platform is a customizable reference design for integrating NVIDIA’s accelerated computing, networking, and AI software with enterprise storage, transforming data into actionable intelligence.
With the NVIDIA AI Data Platform, NetApp customers will be able to connect their data to fuel AI reasoning workloads with agents using NVIDIA AI Enterprise software, including the NVIDIA AI-Q Blueprints and NVIDIA NIM microservices for NVIDIA Llama Nemotron Reason and other models. NVIDIA Blackwell GPUs, NVIDIA networking and the NVIDIA Dynamo open-source inference library drive insights in near real time.
“Traditional computing architectures and data management techniques are not up to the task of helping businesses thrive in the AI era,” said Krish Vitaldevara, Senior Vice President and General Manager, Platform at NetApp. “NVIDIA and NetApp are collaborating to give customers the tools they need to strategically unlock their data to drive the next wave of AI applications. By combining the NVIDIA AI Data Platform with the rich and mature data and AI management capabilities and services of NetApp ONTAP, enterprises can more easily bring AI to their data while maintaining security and compliance to achieve their goals of becoming data-driven businesses.”
NetApp is supporting the vision behind the NVIDIA AI Data Platform by developing the capabilities businesses need to accelerate AI pipelines, including:
Global Metadata Namespace: Customers will be able to securely discover, manage, and analyze all their data across the hybrid multicloud to enable feature extraction and data classification for AI.
Integrated AI Data Pipeline: Customers can more automatically prepare their unstructured data to use in AI applications by tracking incremental changes, leveraging incredibly efficient replication with NetApp SnapMirror®, classifying data, and creating highly compressed vector embeddings to enable semantic searches on data for retrieval augmented generation (RAG) inferencing.
Disaggregated Storage Architecture: Customers will be able to optimize their network and flash speeds and infrastructure costs to achieve high performance with minimal space and power requirements for compute-intensive AI workloads.
NetApp’s support of the NVIDIA AI Data Platform builds on the companies’ longstanding history of collaboration, including the recent announcement of an advanced generative AI data vision and end-to-end integrated solutions that combine NVIDIA AI software and accelerated computing with NetApp intelligent data infrastructure for enterprise RAG to power the future of agentic AI applications.
“Enterprise data is a rich source of information for AI reasoning, but the vast majority of enterprise data is unstructured, making it difficult to extract insights and meaning,” said Kari Briski, Vice President, Generative AI Software for Enterprise at NVIDIA. “Bringing together NetApp and the NVIDIA AI Data Platform creates a data pipeline that’s always on, allowing business data to be readily available to AI agents so they can rapidly access information to make informed decisions.”
To learn how NetApp will help power the future of agentic AI reasoning solutions with NVIDIA, visit the NetApp booth #318 at NVIDIA GTC in San Jose from March 17-21, 2025.
Additional Resources
Powering the Next Generation of AI Infrastructure
AI Solutions
NetApp Storage Now Validated for NVIDIA DGX SuperPOD, NVIDIA Cloud Partners, and NVIDIA-Certified Systems
About NetApp
NetApp is the intelligent data infrastructure company, combining unified data storage, integrated data, operational and workload services to turn a world of disruption into opportunity for every customer. NetApp creates silo-free infrastructure, harnessing observability and AI to enable the industry’s best data management. As the only enterprise-grade storage service natively embedded in the world’s biggest clouds, our data storage delivers seamless flexibility. In addition, our data services create a data advantage through superior cyber resilience, governance, and application agility. Our operational and workload services provide continuous optimization of performance and efficiency for infrastructure and workloads through observability and AI. No matter the data type, workload, or environment, with NetApp you can transform your data infrastructure to realize your business possibilities. Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250318004660/en/
Permalink
https://www.aetoswire.com/en/news/54225241en
Contacts
Media Contact:
Kenya Hayes
NetApp
kenya.hayes@netapp.com
Investor Contact:
Kris Newton
NetApp
kris.newton@netapp.com
Subscribe to:
Posts (Atom)